Board Meeting5 Nov 2026, 12:40 pm
Speciality Medicines Ltd Board Meeting on Nov 12, 2026
AI Summary
Speciality Medicines Ltd has announced a Board of Directors meeting scheduled for November 12, 2026. The primary agenda item is the consideration and approval of the Unaudited Standalone Financial Results for the half-year ended September 30, 2026. Additionally, the company has informed about the closure of the trading window for its insiders, effective from October 1, 2026, until 48 hours after the board meeting concludes, in compliance with SEBI regulations regarding insider trading.
Key Highlights
- Board meeting scheduled for November 12, 2026.
- Agenda includes approval of Unaudited Standalone Financial Results.
- Trading window for insiders closed from October 1, 2026.
- Closure aligns with SEBI's Insider Trading Regulations.
Price Impact
More from SPML